Status | Study |
RECRUITING |
Study Name: Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome Condition: Dengue Fever Date: 2023-10-01 Interventions: 2,00,000 IU Vitamin D3 oral solution in the form of cholecalciferol 4,00,000 IU Vitamin D3 oral solution in the form of cholecalciferol |
Recruiting |
Study Name: Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in Guangzhou Condition: Dengue Fever Date: 2015-10-11 |
Not yet recruiting |
Study Name: Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore Condition: Dengue Fever Date: 2015-10-01 Interventions: Drug: Celgosivir Celgosivir 15 |
Completed |
Study Name: Factors Associated With Poor Dengue Outcomes in Malaysia Condition: Dengue Fever Date: 2015-07-26 |
Completed |
Study Name: The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia Condition: Dengue Fever Date: 2015-07-26 |
Active, not recruiting |
Study Name: Safety and Immunogenicity With Two Different Serotype 2 Potencies of Tetravalent Dengue Vaccine (TDV) in Adults in Singapore Condition: Dengue Fever Date: 2015-04-09 Interventions: Biological: Takeda's Tetravalent Dengue Vaccine Candidate (TDV) |
Active, not recruiting |
Study Name: Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants Condition: Dengue Fever Date: 2014-11-24 Interventions: Biological: Takeda's Tetravalent Dengue Vaccine Candidate (TDV) |
Completed |
Study Name: Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) Condition: Dengue Fever Date: 2014-07-15 Interventions: Drug: TDV Liquid Formulation 1 |
Recruiting |
Study Name: Efficacy and Safety of Ivermectin Against Dengue Infection Condition: Dengue Fever Date: 2014-01-13 Interventions: Drug: 2 days Ivermectin 200-40 |
Active, not recruiting |
Study Name: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) Condition: Dengue Fever Date: 2012-10-04 Interventions: Biological: Biological/Vaccine: 4 µg TDENV-PIV with Alum adjuvant |